Ty Gluckman, MD: Cardiovascular Concerns in 2022

Video

There is concern for cardiovascular patients over missed screenings during the pandemic.

One of the long-term impact of the COVID-19 pandemic is cardiovascular concerns.

With many gyms closed, activities cancelled, and people picking up poor habits

In an interview with HCPLive® during Pri-Med West 2022 in Anaheim, Ty Gluckman, MD, Medical Director of the Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), explained how the pandemic may have resulted in an increase in bad cholesterol results for many.

Gluckman said there is legitimate concern over patients comining in with higher cholesterol because of the bad habits they picked up during the pandemic in regard to food, alcohol, and a lack of exercise.

“It was very sobering to see that year over year increases in both systolic and dystolic blood pressures have gone up, rates of obesirty have gone up,” Gluckman said. “So it is absolutely no question that that access to a lot services has played a role and access to clinicians, especially early on in the pandemic, has created challenges.”

Another concern is the severity of disease.

Many patients did forego appointments and screenings during the initial part of the pandemic due fear of catching COVID-19 in a hospital setting.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
Veeral Sheth, MD: Assessment of EYP-1901 Supplemental Injection Use in Wet AMD | Image Credit: University Retina
© 2024 MJH Life Sciences

All rights reserved.